MIDDLETOWN, Del.—Datwyler's Sealing Solutions unit has opened a new production plant for pharmaceutical components in Middletown.
The $102 million production facility operates to Datwyler's FirstLine standard which focuses on advanced cleanroom technology, automated production, camera inspection and special cleaning processes.
Products include high-quality elastomer components for the growing biotech and pharmaceutical markets. The company expects to carry out certification by customers in the fourth quarter of 2018 and start series production at the beginning of 2019.
The facility not only strengthens Datwyler's position in the U.S.—which the company described as the world's largest pharmaceutical market—it also will increase global first line volume by 50 percent within two years.
Datwyler recently expanded pharmaceutical components production at its Satara site in Pune, India, with the addition of a first line production unit. Earlier this year, the company said it expected samples from the Indian facility to be available by the end of 2018.